blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP3968960

EP3968960 - NANOVESICLES AND ITS USE FOR NUCLEIC ACID DELIVERY [Right-click to bookmark this link]
StatusRequest for examination was made
Status updated on  18.02.2022
Database last updated on 28.06.2024
FormerThe international publication has been made
Status updated on  20.11.2020
Formerunknown
Status updated on  15.05.2020
Most recent event   Tooltip03.06.2024New entry: Renewal fee paid 
Applicant(s)For all designated states
Fundació Hospital Universitari Vall d'Hebron - Institut de Recerca
Pg. Vall d' Hebron, 119-129
08035 Barcelona / ES
For all designated states
Consejo Superior de Investigaciones Científicas (CSIC)
C/ Serrano 117
28006 Madrid / ES
For all designated states
Consorcio Centro de Investigación Biomédica en Red M.P.
C/Monforte de Lemos 3-5
Pabellón 11
28029 Madrid / ES
[2022/12]
Inventor(s)01 / SEGURA GINARD, Miguel Francisco
Passeig Vall d'Hebron, 119-129
08035 BARCELONA / ES
02 / GALLEGO MELCON, Soledad
Passeig Vall d'Hebron, 119-129
08035 BARCELONA / ES
03 / SÁNCHEZ DE TOLEDO CODINA, Josep
Passeig Vall d'Hebron, 119-129
08035 BARCELONA / ES
04 / SORIANO FERNÁNDEZ, Aroa
Passeig Vall d'Hebron, 119-129
08035 BARCELONA / ES
05 / VENTOSA RULL, Nora
Institut de Ciència de Materials de Barcelona (
ICMAB - CSIC) Campus de la UAB
08193 BELLATERRA / ES
06 / VECIANA MIRÓ, Jaume
Institut de Ciència de Materials de Barcelona (
ICMAB - CSIC) Campus de la UAB
08193 BELLATERRA / ES
07 / BOLOIX AMENÓS, Ariadna
Passeig Vall d'Hebron, 119-129
08035 BARCELONA / ES
08 / SEGOVIA RAMOS, Nathaly Verónica
Passeig Camp del Roure 8 Esc. E, 4º 3ª
08227 TERRASSA / ES
 [2022/12]
Representative(s)ZBM Patents - Zea, Barlocci & Markvardsen
Rambla Catalunya, 123
08008 Barcelona / ES
[2022/12]
Application number, filing date20723908.812.05.2020
[2022/12]
WO2020EP63195
Priority number, dateEP2019038237213.05.2019         Original published format: EP 19382372
[2022/12]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2020229469
Date:19.11.2020
Language:EN
[2020/47]
Type: A1 Application with search report 
No.:EP3968960
Date:23.03.2022
Language:EN
The application published by WIPO in one of the EPO official languages on 19.11.2020 takes the place of the publication of the European patent application.
[2022/12]
Search report(s)International search report - published on:EP19.11.2020
ClassificationIPC:A61K9/127, A61K47/28, A61K48/00, C12N15/113, C12N15/88, C12N15/11, A61K31/713, A61K31/7088
[2022/12]
CPC:
C12N15/88 (EP,US); A61K9/1272 (EP,US); A61K31/713 (EP,US);
C12N15/111 (EP,US); C12N15/113 (EP); C12N2310/14 (EP);
C12N2310/141 (EP,US); C12N2320/32 (EP,US) (-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2022/12]
TitleGerman:NANOVESIKEL UND DEREN VERWENDUNG ZUR NUKLEINSÄUREABGABE[2022/12]
English:NANOVESICLES AND ITS USE FOR NUCLEIC ACID DELIVERY[2022/12]
French:NANOVÉSICULES ET LEUR UTILISATION POUR L'ADMINISTRATION D'ACIDES NUCLÉIQUES[2022/12]
Entry into regional phase13.12.2021National basic fee paid 
13.12.2021Designation fee(s) paid 
13.12.2021Examination fee paid 
Examination procedure13.12.2021Examination requested  [2022/12]
13.12.2021Date on which the examining division has become responsible
20.06.2022Amendment by applicant (claims and/or description)
Fees paidRenewal fee
31.05.2022Renewal fee patent year 03
31.05.2023Renewal fee patent year 04
31.05.2024Renewal fee patent year 05
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[ID]WO2017147407  (UNIV TEXAS [US], et al) [ID] 1,2 * Whole document, especially the claims. *;
 [A]EP3281644  (CONSEJO SUPERIOR DE INVESTIG CIENTÍFICAS [ES], et al) [A] 1-27 * Whole document, especially the claims. *;
 [I]US2018049991  (LEE ROBERT J [US]) [I] 1,2 * Whole document, especially §0189-192 *;
 [ID]  - MARY CANO-SARABIA ET AL, "Preparation of Uniform Rich Cholesterol Unilamellar Nanovesicles Using CO 2 -Expanded Solvents", LANGMUIR, US, (20080301), vol. 24, no. 6, doi:10.1021/la7032109, ISSN 0743-7463, pages 2433 - 2437, XP055632170 [ID] 1,2 * the whole document *

DOI:   http://dx.doi.org/10.1021/la7032109
 [ID]  - LIDIA FERRER-TASIES ET AL, "Quatsomes: Vesicles Formed by Self-Assembly of Sterols and Quaternary Ammonium Surfactants", LANGMUIR, US, (20130604), vol. 29, no. 22, doi:10.1021/la4003803, ISSN 0743-7463, pages 6519 - 6528, XP055632173 [ID] 1,2 * the whole document *

DOI:   http://dx.doi.org/10.1021/la4003803
 [ID]  - INGRID CABRERA ET AL, "Multifunctional Nanovesicle-Bioactive Conjugates Prepared by a One-Step Scalable Method Using CO 2 -Expanded Solvents", NANO LETTERS, US, (20130814), vol. 13, no. 8, doi:10.1021/nl4017072, ISSN 1530-6984, pages 3766 - 3774, XP055407817 [ID] 1,2 * the whole document *

DOI:   http://dx.doi.org/10.1021/nl4017072
 [I]  - TATJANA MICHEL ET AL, "Cationic Nanoliposomes Meet mRNA: Efficient Delivery of Modified mRNA Using Hemocompatible and Stable Vectors for Therapeutic Applications", MOLECULAR THERAPY-NUCLEIC ACIDS, (20170901), vol. 8, doi:10.1016/j.omtn.2017.07.013, ISSN 2162-2531, pages 459 - 468, XP055590745 [I] 1,2 * the whole document *

DOI:   http://dx.doi.org/10.1016/j.omtn.2017.07.013
 [I]  - N. GRIMALDI ET AL, "Lipid-based nanovesicles for nanomedicine", CHEMICAL SOCIETY REVIEWS, UK, (20160101), vol. 45, no. 23, doi:10.1039/C6CS00409A, ISSN 0306-0012, pages 6520 - 6545, XP055632040 [I] 1,2 * the whole document *

DOI:   http://dx.doi.org/10.1039/C6CS00409A
 [A]  - ZHANG Y ET AL, "DC-Chol/DOPE cationic liposomes: A comparative study of the influence factors on plasmid pDNA and siRNA gene delivery", INTERNATIONAL JOURNAL OF PHARMACEUTICS, ELSEVIER, NL, vol. 390, no. 2, ISSN 0378-5173, (20100510), pages 198 - 207, (20100129), XP026996942 [A] 1-27 * abstract *
 [A]  - MILCOVICH GESMI ET AL, "Recent advances in smart biotechnology: Hydrogels and nanocarriers for tailored bioactive molecules depot", ADVANCES IN COLLOID AND INTERFACE SCIENCE, ELSEVIER, NL, (20170509), vol. 249, doi:10.1016/J.CIS.2017.05.009, ISSN 0001-8686, pages 163 - 180, XP085248851 [A] 1-27 * the whole document *

DOI:   http://dx.doi.org/10.1016/j.cis.2017.05.009
by applicantWO2006079889
 WO2017147407
    - BUMCROT D et al., Nat Chem Biol, (20060000), vol. 2, pages 711 - 719
    - GRIMALDI N. et al., Chem Soc Rev, (20160000), vol. 45, pages 6520 - 6545
    - CABRERA I et al., Nano Letters, (20130000), vol. 13, no. 8, pages 3766 - 3774
    - CHEMICAL ABSTRACTS, Database accession no. 137056-72-5
    - DANAEI, M. et al., "Impact of Particle Size and Polydispersity Index on the Clinical Applications of Lipidic Nanocarrier Systems", Pharmaceutics, (20180000), vol. 10, page 57
    - ARDIZZONE et al., SMALL, (20180000), vol. 14, no. 16, page 14
    - CANO- SARABIA M et al., Langmuir, (20080000), vol. 24, pages 2433 - 2437
    - ELIZONDO E et al., Nanomed., (20120000), vol. 7, pages 1391 - 1408
    - FERRER-TASIES et al., Langmuir, (20130604), vol. 29, no. 22, pages 6519 - 28
    - LIVAK KJSCHMITTGEN TD, "Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method", Methods, (20010000), vol. 25, pages 402 - 408
    - FERRER-TASIES et al., Langmuir, (20130000), vol. 29, no. 22, pages 6519 - 28
    - LIVAK KJSCHMITTGEN TD, Methods, (20010000), vol. 25, pages 402 - 408
 EP20190382372
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.